During a recent interview, Vice President Kamala Harris made a mistake and referred to the Food and Drug Administration (FDA) as the “Federal Drug Administration.” While it may seem like a small mistake, it highlights the importance of attention to detail, especially for someone in such a high-profile position.
Harris spoke about the changes taking place in the US regarding abortion and the ongoing case challenging the FDA’s approval of the abortion pill mifepristone, which was approved by the FDA over 20 years ago. While discussing the issue, Harris mistakenly referred to the agency as the Federal Drug Administration instead of the FDA.
While this may seem like a small mistake, it is critical for those in positions of power to have a strong attention to detail, especially when discussing significant issues such as abortion. Additionally, the ongoing case challenging the FDA’s approval of mifepristone is a crucial matter that needs to be addressed appropriately.
As passionate Republican voters, we must continue to hold those in positions of power accountable for their mistakes and ensure that they are taking the appropriate actions to address critical issues such as the FDA’s approval of mifepristone.